Genocea Biosciences - 48 Year Dividend History | GNCA

Historical dividend payout and yield for Genocea Biosciences (GNCA) since 1971. The current TTM dividend payout for Genocea Biosciences (GNCA) as of September 16, 2019 is $0.00. The current dividend yield for Genocea Biosciences as of September 16, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.094B $0.000B
Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections, GEN-004 and HSV-2 prophylaxis and malaria. Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio